Paracetamol pills urgently recalled over contamination fears
Paracetamol pills urgently recalled over contamination fears
A statement issued by the Medicines and Healthcare products Regulatory Agency (MHRA) said Chelonia Healthcare Limited is recalling specific batches of Paracetamol 500mg Tablets (100 pots)
An urgent recall has been issued for batches of paracetamol which could be contaminated
(Image: Anton Petrus via Getty Images )
Patients have been urged to return certain batches of paracetamol due to contamination fears, according to an announcement made on Monday. The Medicines and Healthcare products Regulatory Agency (MHRA) said that Chelonia Healthcare Limited, the manufacturer, is recalling specific batches of paracetamol 500mg tablets (100 pots) as a precautionary measure, reports the Mirror.
The urgent recall is reportedly "due to contamination following a small number of complaints of discoloured tablets within the pots" and an alert has been issued to anyone who has bought them.
It advises: "Patients or carers should check to see if they have received tablets from the listed batches of Paracetamol 500 mg Tablets. The batch number can be found on the label of the medicine bottle and on the outer carton.
"These tablets can only be obtained from a pharmacy with a prescription. The number of tablets you will have been given will vary depending on your prescription and you may have only received a small number of tablets." For the latest restaurant news and reviews, sign up to our food and drink newsletter here .
Medicine Details:
Paracetamol 500mg Tablets.
Article continues below
PL: 33414/0126.
Active ingredient: Paracetamol.
SNOMED code: 33554711000001108.
GTIN: 05060014445506.
The statement further added: "The tablets should be 'white capsule-shaped tablets, scored on one side', as per the Patient Information Leaflet (PIL). If you find tablets that are discoloured in any way, in pots from the listed batches, please contact your pharmacist or the healthcare professional who dispensed your prescription.
"Patients who experience adverse reactions or have any questions about the medication, should seek medical attention. Any suspected adverse reactions should also be reported via the MHRA Yellow Card scheme."
Article continues below
The MHRA has classified the recall as Class 2, suggesting that while the defect could result in mistreatment or harm, it is not deemed life-threatening or serious.
Pharmacists have been given explicit instructions: "Stop supplying the above batches immediately. Quarantine all remaining stock and return it to your supplier, using your supplier's approved process."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Wales Online
6 hours ago
- Wales Online
Paracetamol pills urgently recalled over contamination fears
Paracetamol pills urgently recalled over contamination fears A statement issued by the Medicines and Healthcare products Regulatory Agency (MHRA) said Chelonia Healthcare Limited is recalling specific batches of Paracetamol 500mg Tablets (100 pots) An urgent recall has been issued for batches of paracetamol which could be contaminated (Image: Anton Petrus via Getty Images ) Patients have been urged to return certain batches of paracetamol due to contamination fears, according to an announcement made on Monday. The Medicines and Healthcare products Regulatory Agency (MHRA) said that Chelonia Healthcare Limited, the manufacturer, is recalling specific batches of paracetamol 500mg tablets (100 pots) as a precautionary measure, reports the Mirror. The urgent recall is reportedly "due to contamination following a small number of complaints of discoloured tablets within the pots" and an alert has been issued to anyone who has bought them. It advises: "Patients or carers should check to see if they have received tablets from the listed batches of Paracetamol 500 mg Tablets. The batch number can be found on the label of the medicine bottle and on the outer carton. "These tablets can only be obtained from a pharmacy with a prescription. The number of tablets you will have been given will vary depending on your prescription and you may have only received a small number of tablets." For the latest restaurant news and reviews, sign up to our food and drink newsletter here . Medicine Details: Paracetamol 500mg Tablets. Article continues below PL: 33414/0126. Active ingredient: Paracetamol. SNOMED code: 33554711000001108. GTIN: 05060014445506. The statement further added: "The tablets should be 'white capsule-shaped tablets, scored on one side', as per the Patient Information Leaflet (PIL). If you find tablets that are discoloured in any way, in pots from the listed batches, please contact your pharmacist or the healthcare professional who dispensed your prescription. "Patients who experience adverse reactions or have any questions about the medication, should seek medical attention. Any suspected adverse reactions should also be reported via the MHRA Yellow Card scheme." Article continues below The MHRA has classified the recall as Class 2, suggesting that while the defect could result in mistreatment or harm, it is not deemed life-threatening or serious. Pharmacists have been given explicit instructions: "Stop supplying the above batches immediately. Quarantine all remaining stock and return it to your supplier, using your supplier's approved process."
Reuters
7 hours ago
- Reuters
UK's MHRA suspends Valneva's chikungunya vaccine for elderly
June 9 (Reuters) - UK's medicine regulator said on Monday it has temporarily restricted the use of French vaccine maker Valneva's ( opens new tab shot to treat chikungunya, a virus transmitted by mosquitoes, in people aged 65 and above as a precautionary measure. The vaccine, IXCHIQ, was approved by the Medicines and Healthcare products Regulatory Agency (MHRA) in February to protect people aged 18 years and above against chikungunya, but is not yet available in the UK market. "The decision to restrict the licence until further review is based on global data which has highlighted 23 cases of serious adverse reactions, including two cases reporting a fatal outcome, in people aged from 62 to 89 years of age who received the vaccine," the regulator said. The adverse events, opens new tab were reported in the French overseas territory of La Reunion, where a chikungunya outbreak was reported earlier this year. MHRA's decision comes after the European Medicines Agency (EMA), the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) in May suspended, opens new tab the use of the vaccine in the age group. The French Government was the first to take the step in April.
Daily Record
7 hours ago
- Daily Record
Urgent paracetamol recall over contamination fears as people urged to check packets
A class 2 recall has been issued for the following two batches of 500mg tablets. Certain batches of over-the-counter paracetamol are being withdrawn from shelves. The move was made following reports they have been contaminated. Chelonia Healthcare Limited has issued a class 2 recall for two batches of its 500mg tablets (100 pots) after healthcare professionals issued complaints of them containing discoloured tablets. A notice posted to the website Monday, June 9, explains that the incident so far has only affected the batch number 2312010, with the best before date of April 14, 2025. However, as a "precautionary measure", the pharmaceutical firm has also issued a recall for an additional batch code 2312011, best before date May 15, 2025. The additional batch code has been included in the recall "to mitigate any risk, as the investigation and analysis remain ongoing." Healthcare professionals have since been urged to stop supplying the affected batches immediately, with remaining stock to be quarantined and returned to the supplier following the approved process. Patients and carers are being urged to check if they have been prescribed the 500mg paracetamol tablets, which can only be prescribed through a pharmacy. To double check, the batch codes can be found on the label of the medicine bottle and on the outer carton. It is worth noting that the amount of tablets prescribed depends on the prescription provided by a healthcare professional, so some may have less than the affected 100 pots. As per the patient information leaflet (PIL), the tablets will be 'white capsule-shaped tablets, scored on one side.' If a patient or carer notices that the tablets from the affected batch codes have been discoloured in any way, they are being advised to contact their pharmacist or healthcare professional who dispensed the prescription. Anyone who experiences an adverse reaction after taking the tablets are being urged to seek medical attention, with symptoms being reported to the MHRA Yellow Card Scheme.
